Chemical Industries Far East Ltd. AI Stock Analysis
Want to see SG:C05 full AI Analyst Report?
Chemical Industries Far East Ltd. (C05) AI Stock Analysis
Chemical Industries Far East Ltd.
(SGX:C05)
The score is held back primarily by weak recent profitability and a multi-year revenue decline, plus bearish price trend and momentum. Offsetting these negatives are a strong low-debt balance sheet and improved (but still inconsistent) cash generation in 2026; valuation support is limited due to negative earnings and only a modest dividend yield.
Chemical Industries Far East Ltd. (C05) vs. iShares MSCI Singapore ETF (EWS)
- Market Cap
- SGD 35.31M
- Dividend Yield
- 1.08%
- Average Volume (3M)
- 13.20K
- Price to Earnings (P/E)
- 22.2
- Beta (1Y)
- 0.25
- Revenue Growth
- -7.25%
- EPS Growth
- 95.72%
- Country
- Singapore
- Employees
- 80
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals
Chemical Industries Far East Ltd. Business Overview & Revenue Model
Company Description
Incorporated in Singapore in 1962, Chemical Industries (Far East) Limited functions as an investment holding entity primarily involved in the production and sale of chemicals across Singapore and Myanmar. Its operations are organized into two distinc...
Chemical Industries Far East Ltd. Financial Statement Overview
Summary
Financials are mixed: a strong, conservatively levered balance sheet (very low debt and stable equity) supports resilience, but operating performance has deteriorated from 2021–2022 to losses in 2025–2026 amid a multi-year revenue decline. Cash flow improved in 2026 with positive operating and free cash flow, yet historical cash generation has been volatile and profitability is not yet re-established.
Income Statement
42NeutralBalance Sheet
78PositiveCash Flow
55Neutral| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 95.05M | 60.63M | 65.37M | 72.58M | 100.03M | 85.00M |
| Gross Profit | 13.40M | 8.49M | 3.84M | 5.63M | 6.93M | 22.07M |
| EBITDA | 3.84M | 2.54M | -15.09M | 11.73M | 8.91M | 11.06M |
| Net Income | -482.00K | -919.00K | -21.46M | 4.87M | 3.55M | 6.80M |
Balance Sheet | ||||||
| Total Assets | 134.76M | 131.11M | 138.13M | 147.52M | 146.41M | 152.65M |
| Cash, Cash Equivalents and Short-Term Investments | 21.47M | 20.09M | 23.47M | 21.44M | 29.44M | 44.98M |
| Total Debt | 3.45M | 2.29M | 6.71M | 2.60M | 3.59M | 4.69M |
| Total Liabilities | 29.72M | 25.75M | 31.95M | 18.31M | 21.04M | 22.26M |
| Stockholders Equity | 105.04M | 105.36M | 106.18M | 129.21M | 125.37M | 130.39M |
Cash Flow | ||||||
| Free Cash Flow | 1.65M | 1.25M | -621.00K | -7.05M | -14.39M | 4.21M |
| Operating Cash Flow | 3.97M | 3.30M | 9.13M | 4.81M | -8.63M | 6.07M |
| Investing Cash Flow | -2.93M | -2.03M | -9.74M | -11.84M | -5.73M | -1.87M |
| Financing Cash Flow | -5.35M | -5.14M | 3.07M | -1.08M | -1.05M | -990.00K |
Chemical Industries Far East Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:C05, the sentiment is Negative. The current price of 0.47 is below the 20-day moving average (MA) of 0.50, below the 50-day MA of 0.55, and below the 200-day MA of 0.53, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 24.39 is Positive, neither overbought nor oversold. The STOCH value of -4.35 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:C05.
Chemical Industries Far East Ltd. Peers Comparison
Overall Rating
SG:QES72Outperform- SG:C0550Neutral
SG:M1543Neutral
SG:C8R39Underperform
SG:5WV35Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| SG:QES | 72Outperform | SGD 616.26M | 7.64 | 9.08% | 4.25% | 4.17% | -12.40% |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| SG:C05 | 50Neutral | SGD 35.31M | 22.25 | 1.49% | 1.08% | -7.25% | 95.72% |
| SG:M15 | 43Neutral | SGD 11.35M | -1.30 | -164.44% | ― | 25.81% | -30.34% |
| SG:C8R | 39Underperform | SGD 27.84M | -0.56 | -48.10% | ― | -69.91% | -13.56% |
| SG:5WV | 35Underperform | SGD 11.84M | -10.00 | -81.29% | ― | ― | ― |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SG:C05 | Chemical Industries Far East Ltd. | 0.47 | -0.03 | -6.25% | |
| SG:QES | China Sunsine Chemical Holdings Ltd. | 0.63 | -0.12 | -16.22% | |
| SG:M15 | Matex International Limited | 0.02 | 0.00 | 0.00% | |
| SG:5DS | MegaChem Ltd. | 0.45 | 0.02 | 3.45% | |
| SG:5WV | AsiaPhos Limited | 0.01 | 0.00 | 0.00% | |
| SG:C8R | Jiutian Chemical Group Limited | 0.01 | -0.01 | -51.85% |
Chemical Industries Far East Ltd. Corporate Events
Chemical Industries (Far East) Secures Shareholder Backing for Dividend, Board Line-Up and New Constitution
Chemical Industries (Far East) Limited held its annual general meeting in Singapore on 29 July 2026, where shareholders observed a minute of silence for late founder and former chairman Lim Soo Peng and received an operational update from the CEO on...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 01, 2026